BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8372601)

  • 1. Whole-body leucine turnover in adults on conventional treatment for hypopituitarism.
    Beshyah SA; Sharp PS; Gelding SV; Halliday D; Johnston DG
    Acta Endocrinol (Copenh); 1993 Aug; 129(2):158-64. PubMed ID: 8372601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults.
    Beshyah SA; Freemantle C; Shahi M; Anyaoku V; Merson S; Lynch S; Skinner E; Sharp P; Foale R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):73-84. PubMed ID: 7889635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein metabolism in growth hormone deficiency, and effects of growth hormone replacement therapy.
    Russell-Jones DL; Weissberger AJ; Bowes SB; Kelly JM; Thomason M; Umpleby AM; Jones RH; Sönksen PH
    Acta Endocrinol (Copenh); 1993 Jun; 128 Suppl 2():44-7. PubMed ID: 8342393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects on insulin action in adult hypopituitarism of recombinant human GH therapy individually titrated for six months.
    McConnell EM; Atkinson AB; Ennis C; Hadden DR; McCance DR; Sheridan B; Bell PM
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5342-7. PubMed ID: 11701703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men.
    Gibney J; Wolthers T; Johannsson G; Umpleby AM; Ho KK
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E266-71. PubMed ID: 15727949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of recombinant human growth hormone on alternate days is sufficient to increase whole body protein synthesis and lipolysis in growth hormone deficient adults.
    Lucidi P; Laureti S; Santoni S; Lauteri M; Busciantella-Ricci N; Angeletti G; Santeusanio F; De Feo P
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):173-9. PubMed ID: 10671944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
    Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of growth hormone replacement therapy in hypopituitary adults.
    Beshyah SA; Shahi M; Skinner E; Sharp P; Foale R; Johnston DG
    Eur J Endocrinol; 1994 May; 130(5):451-8. PubMed ID: 8180671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory effect of raloxifene and estrogen on the metabolic action of growth hormone in hypopituitary women.
    Birzniece V; Meinhardt U; Gibney J; Johannsson G; Baxter RC; Seibel MJ; Ho KK
    J Clin Endocrinol Metab; 2010 May; 95(5):2099-106. PubMed ID: 20207825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of growth hormone on protein metabolism in adult growth hormone deficient patients.
    Russell-Jones DL; Weissberger AJ; Bowes SB; Kelly JM; Thomason M; Umpleby AM; Jones RH; Sönksen PH
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):427-31. PubMed ID: 8319375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.
    Lucidi P; Lauteri M; Laureti S; Celleno R; Santoni S; Volpi E; Angeletti G; Santeusanio F; De Feo P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):353-7. PubMed ID: 9467540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
    Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
    Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
    Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
    Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.
    Weaver JU; Monson JP; Noonan K; John WG; Edwards A; Evans KA; Cunningham J
    J Clin Endocrinol Metab; 1995 Jan; 80(1):153-9. PubMed ID: 7829604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women.
    Wolthers T; Hoffman DM; Nugent AG; Duncan MW; Umpleby M; Ho KK
    Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1191-6. PubMed ID: 11701433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth hormone (GH)-insulin-like growth factor axis during testosterone replacement therapy in GH-treated hypopituitary males.
    Fisker S; Nørrelund H; Juul A; Skakkebaek NE; Christiansen JS; Jørgensen JO
    Growth Horm IGF Res; 2001 Apr; 11(2):104-9. PubMed ID: 11472076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.